These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34493833)

  • 1. Pharmacometric approach to assist dosage regimen design in neonates undergoing therapeutic hypothermia.
    Matcha S; Raj EA; Mahadevan R; Raju AP; Rajesh V; Lewis LE; Mallayasamy S
    Pediatr Res; 2022 Jul; 92(1):249-254. PubMed ID: 34493833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia.
    Frymoyer A; Meng L; Bonifacio SL; Verotta D; Guglielmo BJ
    Pharmacotherapy; 2013 Jul; 33(7):718-26. PubMed ID: 23553582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Performance of Population Pharmacokinetic Models for Amikacin in Term Neonates.
    Matcha S; Dillibatcha J; Raju AP; Chaudhari BB; Moorkoth S; Lewis LE; Mallayasamy S
    Paediatr Drugs; 2023 May; 25(3):365-375. PubMed ID: 36943583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population Pharmacokinetics of Gentamicin in Neonates with Hypoxemic-Ischemic Encephalopathy Receiving Controlled Hypothermia.
    Cies JJ; Habib T; Bains V; Young M; Menkiti OR
    Pharmacotherapy; 2018 Nov; 38(11):1120-1129. PubMed ID: 30300445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered gentamicin pharmacokinetics in term neonates undergoing controlled hypothermia.
    Bijleveld YA; de Haan TR; van der Lee HJ; Groenendaal F; Dijk PH; van Heijst A; de Jonge RC; Dijkman KP; van Straaten HL; Rijken M; Zonnenberg IA; Cools F; Zecic A; Nuytemans DH; van Kaam AH; Mathot RA;
    Br J Clin Pharmacol; 2016 Jun; 81(6):1067-77. PubMed ID: 26763684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive performance of a gentamicin population pharmacokinetic model in neonates receiving full-body hypothermia.
    Sampson MR; Frymoyer A; Rattray B; Cotten CM; Smith PB; Capparelli E; Bonifacio SL; Cohen-Wolkowiez M
    Ther Drug Monit; 2014 Oct; 36(5):584-9. PubMed ID: 25225917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulated Comparison of a Bayesian Clinical Decision Support System Versus Standard of Care For Achieving Gentamicin Pharmacokinetic Targets in Neonates.
    Yu CZ; Myers SR; Faldasz JD
    Pediatr Infect Dis J; 2020 Apr; 39(4):313-317. PubMed ID: 32032171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amikacin Pharmacokinetics To Optimize Dosing in Neonates with Perinatal Asphyxia Treated with Hypothermia.
    Cristea S; Smits A; Kulo A; Knibbe CAJ; van Weissenbruch M; Krekels EHJ; Allegaert K
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
    Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
    Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentamicin pharmacokinetics in neonates undergoing therapeutic hypothermia.
    Mark LF; Solomon A; Northington FJ; Lee CK
    Ther Drug Monit; 2013 Apr; 35(2):217-22. PubMed ID: 23503448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a dosage individualization table for extended-interval gentamicin in neonates.
    Dersch-Mills D; Akierman A; Alshaikh B; Yusuf K
    Ann Pharmacother; 2012; 46(7-8):935-42. PubMed ID: 22739714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates.
    DiCenzo R; Forrest A; Slish JC; Cole C; Guillet R
    Pharmacotherapy; 2003 May; 23(5):585-91. PubMed ID: 12741432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hypothermia treatment on gentamicin pharmacokinetics in neonates with hypoxic-ischaemic encephalopathy: A systematic review and meta-analysis.
    Choi DW; Park JH; Lee SY; An SH
    J Clin Pharm Ther; 2018 Aug; 43(4):484-492. PubMed ID: 29781085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of gentamicin in newborns with moderate-to-severe hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia.
    Ting JY; Kwan E; McDougal A; Osiovich H
    Indian J Pediatr; 2015 Feb; 82(2):119-25. PubMed ID: 25070069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Otoacoustic emission screen results in critically ill neonates who received gentamicin in the first week of life.
    Cooper AC; Commers AR; Finkelstein M; Lipnik PG; Tollefson LM; Wilcox RA; Hoff DS
    Pharmacotherapy; 2011 Jul; 31(7):649-57. PubMed ID: 21923451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.
    Nielsen EI; Sandström M; Honoré PH; Ewald U; Friberg LE
    Clin Pharmacokinet; 2009; 48(4):253-63. PubMed ID: 19492870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Every 36-h gentamicin dosing in neonates with hypoxic-ischemic encephalopathy receiving hypothermia.
    Frymoyer A; Lee S; Bonifacio SL; Meng L; Lucas SS; Guglielmo BJ; Sun Y; Verotta D
    J Perinatol; 2013 Oct; 33(10):778-82. PubMed ID: 23702622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of a dosage individualization table for extended interval gentamicin in neonates beyond the first week of life.
    Dersch-Mills D; Akierman A; Alshaikh B; Sundaram A; Yusuf K
    J Matern Fetal Neonatal Med; 2016; 29(9):1451-6. PubMed ID: 26043646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of gentamicin peak and trough concentrations from six extended-interval dosing protocols for neonates.
    Murphy JE
    Am J Health Syst Pharm; 2005 Apr; 62(8):823-7. PubMed ID: 15821275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gentamicin Dosing in Neonates with Normal Renal Function: Trough and Peak Levels.
    O'Connor K; Davies MW; Koorts P; Cartwright DW; Whitfield K
    Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):677-684. PubMed ID: 34370216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.